Qube Research & Technologies (QRT)
ALGS icon

Qube Research & Technologies (QRT)’s Aligos Therapeutics ALGS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,947
Closed -$94.8K – 3424
2024
Q3 		$94.8K Buy
+10,947
New +$136K ﹤0.01% 2759
2024
Q2 		– Hold
0
– – – 3749
2024
Q1 		– Hold
0
– – – 4361
2023
Q4 		– Hold
0
– – – 4267
2023
Q3 		– Hold
0
– – – 4028
2022
Q4 		– Sell
-641
Closed -$18K – 2427
2022
Q3 		$18K Sell
641
-107
-14% -$3.55K ﹤0.01% 2308
2022
Q2 		$23K Buy
+748
New +$25.4K ﹤0.01% 2246
2021
Q3 		– Sell
-609
Closed -$311K – 2150
2021
Q2 		$311K Buy
609
+5
+0.8% +$3.19K ﹤0.01% 1555
2021
Q1 		$343K Buy
+604
New +$402K 0.01% 1389

Other funds holding ALGS

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ALGS Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of Aligos Therapeutics (ALGS) in Q4 2024, closing a stake of 10,947 shares — an estimated $94.8K sold.

Qube Research & Technologies (QRT) first reported a position in ALGS in Q1 2021 and held it in 5 quarters. The position peaked at $343K in Q1 2021. 34 funds tracked by Wall St. Rank hold ALGS as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining Aligos Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 10,947 Aligos Therapeutics shares in Q4 2024, an estimated $94.8K.
  • Qube Research & Technologies (QRT) first reported a position in Aligos Therapeutics in Q1 2021 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Aligos Therapeutics position peaked at $343K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.